| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Options Exercise | $0 | +3,394 | +9.5% | $0.000000 | 38,999 | 02 Oct 2022 | Direct | F1 |
| transaction | BSX | Common Stock | Tax liability | $38,614 | -997 | -2.6% | $38.73 | 38,002 | 02 Oct 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -3,394 | -100% | $0.000000* | 0 | 02 Oct 2022 | Common Stock | 3,394 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F2 | Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 2, 2018, the first anniversary of the date of grant. |